Amiloride but Not Memantine Reduces Neurodegeneration, Seizures and Myoclonic Jerks in Rats with Cardiac Arrest-Induced Global Cerebral Hypoxia and Reperfusion

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Tai, Kwok Keung ^a,b   Truong, Daniel D ^a,b  

^a LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

^b Parkinson's and Movement Disorder Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID SENSING ION CHANNEL; AMILORIDE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; ZONIPORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN HYPOXIA; BRAIN PERFUSION; BRAIN REPERFUSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MODEL; DRUG ACTIVITY; HEART ARREST; MALE; MYOCLONUS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; RAT; SEIZURE;

ACID SENSING ION CHANNELS; AMILORIDE; ANIMALS; BRAIN INJURIES; HEART ARREST; HYPOXIA, BRAIN; MALE; MEMANTINE; MYOCLONUS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; REPERFUSION INJURY; SEIZURES;

RATTUS;

EID: 84875981269     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060309     Document Type: Article

References (40)

1. Olney JW, (1969) Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164: 719-721.
2. Olney JW, Sharpe LG, (1969) Brain lesions in an infant rhesus monkey treated with monsodium glutamate. Science 166: 386-388.
3. Goldberg MP, Weiss JH, Pham PC, Choi DW, (1987) N-methyl-D-aspartate receptors mediate hypoxic neuronal injury in cortical culture. J Pharmacol Exp Ther 243: 784-791.
4. Choi DW, (1990) Rothman (1990) The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu.Rev. Neurosci13: 171-182.
5. Simon RP, Swan JH, Griffiths T, Meldrum BS, (1984) Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226: 850-852.
6. Faden AI, Demediuk P, Panter SS, Vink R, (1989) The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244: 798-800.
7. Del Zoppo GJ, (1995) Why do all drugs work in animals but none in stroke patients? 1. Drugs promoting cerebral blood flow. J Intern Med 237: 79-88.
8. Grotta J, (1995) Why do all drugs work in animals but none in stroke patients? 2. Neuroprotective therapy. J Intern Med 237: 89-94.
9. Morris GF, Bullock R, Marshall SB, Marmarou A, Maas A, et al. (1999) Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators. J Neurosurg 91: 737-743.
10. Birmingham K, (2002) Future of neuroprotective drugs in doubt. Nat Med 8: 5.
11. Siesjo BK, Zhao Q, Pahlmark K, Siesjo P, Katsura K, et al. (1995) Glutamate, calcium, and free radicals as mediators of ischemic brain damage. Ann Thorac Surg 59: 1316-1320.
12. Xiong ZG, Zhu XM, Chu XP, Minami M, Hey J, et al. (2004) Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell 118: 687-698.
13. Marala RB, Brown JA, Kong JX, Tracey WR, Knight DR, et al. (2002) Zoniporide: a potent and highly selective inhibitor of human Na(+)/H(+) exchanger-1. Eur J Pharmacol. 451: 37-41.
14. Hossmann KA, (1998) Experimental models for the investigation of brain ischemia. Cardiovasc Res 39: 106-120.
15. Tache Y, Vale W, Rivier J, Brown M, (1980) Brain regulation of gastric secretion: influence of neuropeptides. Proc Natl Acad Sci U S A 77: 5515-5519.
16. Tai KK, Pham L, Truong DD, (2009) Intracisternal administration of glibenclamide or 5-hydroxydecanoate does not reverse the neuroprotective effect of ketogenic diet against ischemic brain injury-induced neurodegeneration. Brain Inj 23: 1081-1088.
17. Truong DD, Matsumoto RR, Schwartz PH, Hussong MJ, Wasterlain CG, (1994) Novel rat cardiac arrest model of posthypoxic myoclonus. Mov Disord 9: 201-206.
18. Truong DD, Kanthasamy A, Nguyen B, Matsumoto R, Schwartz P, (2000) Animal models of posthypoxic myoclonus: I. Development and validation. Mov Disord 15Suppl 1: 26-30.
19. Truong DD, Kirby M, Kanthasamy A, Matsumoto RR, (2002) Posthypoxic myoclonus animal models. Adv Neurol 89: 295-306.
20. Tai KK, Truong DD, (2005) Post-hypoxic myoclonus induces Fos expression in the reticular thalamic nucleus and neurons in the brainstem. Brain Res 1059: 122-128.
21. Tai KK, Truong DD, (2010) Memantine exacerbates myoclonic jerks in a rat model of posthypoxic myoclonus. Brain Res 1343: 194-198.
22. Tai KK, Truong DD, (2007) NMDA receptor-mediated excitotoxicity contributes to the cerebral hypoxic injury of a rat model of posthypoxic myoclonus. Brain Res 1133: 209-215.
23. Tai KK, Nguyen N, Pham L, Truong DD, (2008) Ketogenic diet prevents cardiac arrest-induced cerebral ischemic neurodegeneration. J Neural Transm 115: 1011-1017.
24. Castella M, Buckberg GD, Tan Z, (2005) Neurologic preservation by Na+-H+ exchange inhibition prior to 90 minutes of hypothermic circulatory arrest. Ann Thorac Surg 79: 646-654.
25. Allen BS, Veluz JS, Buckerg GD, Aeberhard E, Ignarro LJ, (2003) Deep hypothermic circulatory arrest and global reperfusion injury: avoidance by making a pump prime reperfusate- a new concept. J Thorac Cardiovasc Surg 125: 625-632.
26. Kleyman TR, Cragoe EJ Jr, (1988) Amiloride and its analogs as tools in the study of ion transport. J Membr Biol 105: 1-21.
27. Gomez-Villafuertes R, Mellstrom B, Naranjo JR, (2007) Searching for a role of NCX/NCKX exchangers in neurodegeneration. Mol Neurobiol 35: 195-202.
28. Helfaer MA, Ichord RN, Martin LJ, Hurn PD, Castro A, et al. (1998) Treatment with the competitive NMDA antagonist GPI 3000 does not improve outcome after cardiac arrest in dogs. Stroke 29: 824-829.
29. Leahy JC, Chen Q, Vallano ML, (1994) Chronic mild acidosis specifically reduces functional expression of N-methyl-D-aspartate receptors and increases long-term survival in primary cultures of cerebellar granule cells. Neuroscience 63: 457-470.
30. Giffard RG, Monyer H, Christine CW, Choi DW, (1990) Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygen-glucose deprivation neuronal injury in cortical cultures. Brain Res 506: 339-342.
31. Choi DW, (1990) Possible mechanisms limiting N-methyl-D-aspartate receptor overactivation and the therapeutic efficacy of N-methyl-D-aspartate antagonists. Stroke 21: III20-22.
32. Meldrum B, Evans M, Griffiths T, Simon R, (1985) Ischaemic brain damage: the role of excitatory activity and of calcium entry. Br J Anaesth 57: 44-46.
33. Rothman SM, Olney JW, (1986) Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19: 105-111.
34. Waldmann R, Champigny G, Bassilana F, Heurteaux C, Lazdunski M, (1997) A proton-gated cation channel involved in acid-sensing. Nature 386: 173-177.
35. Li M, Inoue K, Branigan D, Kratzer E, Hansen JC, et al. (2010) Acid-sensing ion channels in acidosis-induced injury of human brain neurons. J Cereb Blood Flow Metab 30: 1247-1260.
36. Lin YC, Liu YC, Huang YY, Lien CC (2010) High-density expression of Ca2+-permeable ASIC1a channels in NG2 glia of rat hippocampus. PLoS One 5.
37. Yu Y, Chen Z, Li WG, Cao H, Feng EG, et al. (2010) A nonproton ligand sensor in the acid-sensing ion channel. Neuron 68: 61-72.
38. Ali A, Ahmad FJ, Pillai KK, Vohora D, (2004) Evidence of the antiepileptic potential of amiloride with neuropharmacological benefits in rodent models of epilepsy and behavior. Epilepsy Behav 5: 322-328.
39. Ali A, Ahmad FJ, Pillai KK, Vohora D, (2005) Amiloride protects against pentylenetetrazole-induced kindling in mice. Br J Pharmacol 145: 880-884.
40. Luszczki JJ, Sawicka KM, Kozinska J, Dudra-Jastrzebska M, Czuczwar SJ, (2009) Amiloride enhances the anticonvulsant action of various antiepileptic drugs in the mouse maximal electroshock seizure model. J Neural Transm 116: 57-66.